• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    9/3/25 7:32:46 AM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email
    ctev-20250903
    0001793229FALSE00017932292025-09-032025-09-03

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported):
    September 3, 2025

    Claritev Corporation
    (Exact name of registrant as specified in its charter)
    Delaware001-3922884-3536151
    (State or other jurisdiction of incorporation)
    (Commission File Number)
    (IRS Employer Identification No.)
    7900 Tysons One Place, Suite 400
    McLean, Virginia 22102
    (212) 780-2000
    (Address, including zip code, and telephone number,
    including area code, of registrant’s principal executive offices)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading
    Symbol(s)
    Name of each exchange on which registered
    Shares of Class A Common Stock,
    $0.0001 par value per share
    CTEVNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐




    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 7.01 Regulation FD Disclosure

    Beginning on September 3, 2025, Claritev Corporation (the "Company") will be making a slide presentation available on its website for investors. A copy of this slide presentation is attached hereto as Exhibit 99.1.

    The Company is furnishing the information in this Item 7.01 of this Current Report on Form 8-K and in Exhibit 99.1 to comply with Regulation FD. Such information shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.



    Item 9.01    Financial Statements and Exhibits.
     (d) Exhibits
    The following exhibits are included in this Form 8-K:
    99.1
    Slide Presentation dated September 3, 2025
    104Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document).




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Dated:    September 3, 2025



                                    Claritev Corporation

                                    By:    /s/ Douglas M. Garis         
                                    Name:    Douglas M. Garis
                                    Title:    Executive Vice President and Chief Financial Officer



    Get the next $CTEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Corporation Announces Participation at Upcoming Conferences

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in person at the following conferences in September 2025: 2025 Wells Fargo Healthcare Conference – Wednesday, September 3, 2025, at the Encore Boston Harbor, Boston, MA (including a presentation at approximately 8:45 am Eastern Time) Morgan Stanley 23rd Annual Global Healthcare Conference – Tuesday, September 9, 2025, at the Sheraton New York Times Square Hotel, New York, NY (including a fireside chat at approximately 4:05 pm Eastern Time)

    8/27/25 4:05:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Second Quarter 2025 Results

    Q2 2025 Revenues of $241.6 million, Net Loss of $62.6 million, and Adjusted EBITDA of $154.0 million (Adjusted EBITDA Margin of 63.8%) Full-year 2025 guidance updates to Revenue range (flat to +2% vs. 2024), Free Cash Flow range (usage of $20 million to generation of $20 million for year) and Capital Expenditures ($170 million to $180 million for year) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2025. "Claritev is truly delivering in the year of The Turn. We returned to growth m

    8/6/25 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Joins athenahealth's Marketplace Program to Empower Providers with Price Intelligence for Stronger Financial Outcomes

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with athenahealth, Inc. through the company's award-winning athenahealth® Marketplace program. Now available to athenahealth's growing network of healthcare providers, the newly integrated CompleteVue™ enables financial impact through the power of publicly available price transparency data, actionable insights and powerful analytics. The athenahealth Marketplace empowers athenahealth customers to easily discover and implement solutions that meet their unique needs, fostering

    7/17/25 3:45:00 PM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., CEO & Executive Chair Dalton Travis bought $248,421 worth of shares (4,282 units at $58.02) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/12/25 4:19:12 PM ET
    $CTEV
    Real Estate

    EVP, Chief Operating Officer Hogge Jerome bought $300,771 worth of shares (5,621 units at $53.51), increasing direct ownership by 7% to 90,023 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/11/25 4:21:15 PM ET
    $CTEV
    Real Estate

    EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/20/25 4:24:37 PM ET
    $CTEV
    Real Estate

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Claritev upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Claritev from Neutral to Overweight and set a new price target of $44.00

    5/29/25 8:13:13 AM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director White Dale A. gifted 201,652 shares and received a gift of 201,652 shares, decreasing direct ownership by 56% to 160,080 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/25/25 6:30:34 PM ET
    $CTEV
    Real Estate

    Pres., CEO & Executive Chair Dalton Travis bought $248,421 worth of shares (4,282 units at $58.02) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/12/25 4:19:12 PM ET
    $CTEV
    Real Estate

    EVP, Chief Operating Officer Hogge Jerome bought $300,771 worth of shares (5,621 units at $53.51), increasing direct ownership by 7% to 90,023 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/11/25 4:21:15 PM ET
    $CTEV
    Real Estate

    $CTEV
    SEC Filings

    View All

    Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    9/3/25 7:32:46 AM ET
    $CTEV
    Real Estate

    SEC Form EFFECT filed by Claritev Corporation

    EFFECT - Claritev Corp (0001793229) (Filer)

    8/20/25 12:15:14 AM ET
    $CTEV
    Real Estate

    SEC Form S-3 filed by Claritev Corporation

    S-3 - Claritev Corp (0001793229) (Filer)

    8/7/25 4:23:01 PM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports Second Quarter 2025 Results

    Q2 2025 Revenues of $241.6 million, Net Loss of $62.6 million, and Adjusted EBITDA of $154.0 million (Adjusted EBITDA Margin of 63.8%) Full-year 2025 guidance updates to Revenue range (flat to +2% vs. 2024), Free Cash Flow range (usage of $20 million to generation of $20 million for year) and Capital Expenditures ($170 million to $180 million for year) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2025. "Claritev is truly delivering in the year of The Turn. We returned to growth m

    8/6/25 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Second Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its second quarter 2025 financial results on Wednesday, August 6, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadshow.com/eve

    7/10/25 8:30:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports First Quarter 2025 Results

    – Q1 2025 Revenues of $231.3 million, Net Loss of $71.3 million, and Adjusted EBITDA of $142.1 million (Adjusted EBITDA Margin of 61.4%) – Reaffirms full-year guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2025. "There is tremendous excitement at Claritev as we kick off 2025 - our ‘Year of The Turn.' We've already announced major milestones, and our teams are amplifying this positive momentum as we continue on our planned course for the year," said Travis Dalton, Chairman, CEO a

    5/8/25 6:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate